v3.26.1
FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 31, 2026
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

NOTE 6: -   FAIR VALUE MEASUREMENTS

Under U.S. GAAP, fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants and requires that assets and liabilities carried at fair value are classified and disclosed in the following three categories:

Level 1 -

Valuations based on quoted prices in active markets for identical assets that the Company has the ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

Level 2 -

Valuations based on one or more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.

Level 3 -

Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The availability of observable inputs can vary from instrument to instrument and is affected by a wide variety of factors, including, for example, the type of investment, the liquidity of markets and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment, and the investments are categorized as Level 3.

NOTE 6: - FAIR VALUE MEASUREMENTS (Cont.)

The carrying amounts of cash and cash equivalents, short-term restricted bank deposits, trade receivables, other accounts receivable and prepaid expenses, trade payables and other accounts payable and accrued expenses approximate their fair value due to the short-term maturity of such instruments. In addition, the Callodine Loan Facility approximates its fair value. The Orbimed Warrant liability was measured at fair value using Level 3 unobservable inputs.

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis:

  ​

March 31, 2026

  ​

Fair Value

  ​

Level 1

Level 2

Level 3

Financial assets:

  ​

  ​

Cash and cash equivalents:

  ​

U.S. treasury notes

$

6,367

  ​

$

$

6,367

$

Total financial assets

$

6,367

$

$

6,367

$

  ​

  ​

Financial liabilities:

  ​

  ​

Orbimed Warrant liability

$

23

$

$

$

23

Total financial liabilities

$

23

$

$

$

23

  ​

December 31, 2025

  ​

Fair Value

  ​

Level 1

Level 2

Level 3

Financial assets:

  ​

  ​

Cash and cash equivalents:

  ​

U.S. treasury notes

$

12,761

  ​

$

$

12,761

$

Total financial assets

$

12,761

$

$

12,761

$

  ​

  ​

Financial liabilities:

  ​

  ​

Orbimed Warrant liability

43

  ​

43

Pre-Funded Warrant liability

1,423

  ​

1,423

Total financial liabilities

$

1,466

$

$

1,423

$

43